Publish Novellas 30 March 2022
EPISODE 4 – FUTURES
Time catches up with mature members of the new corporation as others assume key responsibilities.
It takes nearly a year for Clarkson Biogenic to build out and staff an appropriate lab. Titan and Radium begin working full-time and everyone is on payroll with health benefits. The children oversee clinical trials, with a goal of getting FDA approval for human trials.
Mae has no problems keeping up with the demands of running a growing company. In fact, she is excited to see her dream materialize after putting her career on hold for much of her life.
Robby is slowing down, working half days to go home and rest. One evening, he talks to Mae about his diminishing capacity.
“I never thought I would say this, but I am getting too old to keep up with you. Perhaps I need a dose of this elixir we’re peddling.”
“I can appreciate that starting a new career after thirty years is challenging. None of us expect you to put in 60-hour weeks. We still need your objective mind to author clinical trials that answer important questions.
“But now that we are a licensed company, we cannot participate in human trials without FDA approval. That is something that is at least five years away.”
“My skepticism got the best of me. I waited until the ninth inning. Now my wife is finally allowed to bat and you are hitting the ball out of the park and running circles around me like a 20-year old.”
“Aging is a natural part of life. We are the pioneers who set out to disrupt it. There is a price for that,” Mae responds.”
With evident body aches, Robby assures, “I still believe in you and will support any way I can, but right now, I just need some rest.”
“Sure honey, but you should schedule a medical checkup. Perhaps you need some vitamins.”
“Okay, I’ll schedule an appointment tomorrow. Good night.”
“Good night. I will stay up a bit longer to work on some reports.”
A subsequent doctor visit reveals three medical conditions. Robby is severely deficient in vitamin D. His doctor prescribes daily doses of 50,000 IU tablets for one month.
A lifelong sedentary job has contributed to Robby’s enlarged prostate. This makes it uncomfortable to sit for long periods of time. Fortunately, there is no cancer.
Robby also has a cardiopulmonary condition contributing to his fatigue. Contrary to how it sounds, congestive heart failure does not mean the heart stops beating. Rather, the heart does not pump enough blood. This results in fatigue, shortness of breath, and bloating. With the best care, he does not survive to see the human trials of their product.
As a widow, Mae pushes through her grief, leading the company to its public offering, making Clarkson Biogenic a billion dollar corporation. With her youthful appearance at age 70, she becomes the face of the marketing campaign for their new treatment called Forever 29. The company expands into biopharmaceutical skin care products. By age 75, Mae transfers the role of CEO to her son, Titan, and limits her day-to-day involvement in Clarkson Biogenic.
Her face on billboards attracts young suitors. Mae accepts the proposal of a smart 35-year-old millionaire who underwent the company’s DNA modification. As a widow, she reasons, ‘If you’re going to buy a new car, you might as well get one with low mileage.’ She enjoyed life as a loyal and supportive homemaker. Then she rose to become a titan in the anti-aging industry.
In this third iteration of her life, she settles down in her lavish mansions to answer the burning question raised by her first husband. Will offspring of two genetically modified parents inherit longevity?